New research indicates that patients who discontinue blockbuster GLP-1 drugs like Wegovy and Mounjaro can put back on lost weight at a significantly accelerated pace than those who halt traditional diet and exercise plans.
Published data in a prominent health publication points out that while overweight individuals frequently drop about a fifth of their body weight while using the jabs, the mass comes back at an estimated rate of 0.8 kg per month once they quit.
"Individuals purchasing these medications should be aware of the potential of rapid weight regain when the treatment is stopped," warns lead investigator Dr. Susan Jebb.
This pace of recovery suggests a reversion to original mass within about one and a half years.
Comparing Treatments
The study, which looked at dozens of trials involving thousands of patients, compared the effects of GLP-1 agonists with older methods.
The team emphasize that people who lose weight through diet and exercise generally have a slower weight regain—perhaps 0.1 kg a month—once they finish.
Understanding the Quick Regain
Experts suggest the way of the jabs explains the heightened rebound.
The injections mimic a natural hormone called GLP-1, which controls appetite.
"Long-term administration of GLP-1 concentrations several times higher than the body's typical production could lead to the body to produce less of its own natural hormone, and could lessen sensitivity to its effects," said Dr. Adam Collins, a dietetics expert.
"Discontinuation of this medication leads to hunger is no longer kept in check, making excessive eating much more probable."
A Lifelong Issue?
Medical guidelines advise the jabs for individuals with obesity-related health risks, alongside recommended diet and exercise modifications.
Many experts argue that, due to the high risk of weight regain, the treatment should be considered long-term.
This opinion is echoed by pharmaceutical companies, who say that the results "emphasize the chronic nature of excess weight," similar to managing diseases like diabetes.
User Accounts
Individuals who have stopped the jabs report a intense return of cravings.
"It felt as if a switch that goes on and you become extremely hungry," recalled one woman.
This difficulty is worsened if users have not established permanent lifestyle or habit changes during therapy.
Widespread Adoption
Figures show that millions of adults in the UK have used these injections in the past year, with interest remaining high.
- Use is greater among women compared to males.
- The middle-aged demographic shows the greatest level of interest.
- Many access the medications through private prescriptions rather than public health services.
In conclusion, researchers stress that while the jabs are effective agents for weight loss, they are not a magic cure and lasting health benefits likely depends on integrated lifestyle changes.
